Litigation Details for INTRA-CELLULAR THERAPIES, INC. v. HETERO USA, INC. (D.N.J. 2024)
✉ Email this page to a colleague
INTRA-CELLULAR THERAPIES, INC. v. HETERO USA, INC. (D.N.J. 2024)
| Docket | ⤷ Start Trial | Date Filed | 2024-08-29 |
| Court | District Court, D. New Jersey | Date Terminated | 2025-07-08 |
| Cause | 35:271 Patent Infringement | Assigned To | Michael Andre Shipp |
| Jury Demand | None | Referred To | Brendan Day |
| Patents | 10,695,345; 10,960,009; 11,026,951; 11,052,084; 11,690,842; 11,753,419; 11,806,348; 11,980,617; 12,070,459; 8,648,077; 9,956,227; RE48,839 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in INTRA-CELLULAR THERAPIES, INC. v. HETERO USA, INC.
Details for INTRA-CELLULAR THERAPIES, INC. v. HETERO USA, INC. (D.N.J. 2024)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2024-08-29 | External link to document | |||
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
